Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%85 Return-on-Tangible-Equity is 28.16% as of Jun. 2026, which is 81% above its 10-year median of 15.57. GuruFocus rates ISX:SOHO with a GF Score™ of 85/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 115 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 76.52% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. PT Soho Global Health Tbk's annualized net income for the quarter that ended in Jun. 2026 was Rp732,256 Mil. PT Soho Global Health Tbk's average shareholder tangible equity for the quarter that ended in Jun. 2026 was Rp2,600,677 Mil. Therefore, PT Soho Global Health Tbk's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 28.16%.
The historical rank and industry rank for PT Soho Global Health Tbk's Return-on-Tangible-Equity or its related term are showing as below:
ISX:SOHO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.25 Med: 15.57 Max: 25.68
Current: 25.68
During the past 7 years, PT Soho Global Health Tbk's highest Return-on-Tangible-Equity was 25.68%. The lowest was 9.25%. And the median was 15.57%.
ISX:SOHO's Return-on-Tangible-Equity is ranked better than 76.52% of 115
companies
in the Medical Distribution industry
Industry Median: 8.09
vs ISX:SOHO: 25.68
PT Soho Global Health Tbk (ISX:SOHO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Soho Global Health Tbk Return-on-Tangible-Equity Related Terms
PT Soho Global Health Tbk Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for PT Soho Global Health Tbk's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Soho Global Health Tbk Return-on-Tangible-Equity Chart
ISX:SOHO vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, PT Soho Global Health Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 28.16% mean?
PT Soho Global Health Tbk (ISX:SOHO) has a Return-on-Tangible-Equity of 28.16% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Soho Global Health Tbk and its competitors. This is 81% above median its historical median of 15.57. Over the past decade, PT Soho Global Health Tbk's Return-on-Tangible-Equity has ranged from 9.25 to 25.68. According to the industry distribution chart, PT Soho Global Health Tbk ranks #27 out of 115 companies in the Medical Distribution industry, placing it in the top 23.5%.
Is PT Soho Global Health Tbk's Return-on-Tangible-Equity too high?
PT Soho Global Health Tbk's current Return-on-Tangible-Equity of 28.16% is 81% above median its 10-year median of 15.57. Over the past 10 years, this metric has ranged from a low of 9.25 to a high of 25.68. The Medical Distribution industry median Return-on-Tangible-Equity is 8.09. PT Soho Global Health Tbk's value of 28.16% is 248.1% above this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #27 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Soho Global Health Tbk has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #27 out of 115 companies for Return-on-Tangible-Equity. This places PT Soho Global Health Tbk in the top 24% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 8.09. PT Soho Global Health Tbk's value of 28.16% is 248.1% above this benchmark. Historically, PT Soho Global Health Tbk's own Return-on-Tangible-Equity has ranged from 9.25 to 25.68 over the past decade. While the company's 10-year median is 15.57 vs. the industry median of 8.09, PT Soho Global Health Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.09, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current Return-on-Tangible-Equity of 28.16% is 248.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current Return-on-Tangible-Equity is 28.16%, which is 81% above median its own 10-year median of 15.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current Return-on-Tangible-Equity is 28.16%, which is 81% above median its 10-year median of 15.57 and 248.1% above the Medical Distribution industry median of 8.09. PT Soho Global Health Tbk's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current Return-on-Tangible-Equity is 28.16% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
Return-on-Tangible-Equity: 28.16% (81% above median its 10-year median of 15.57)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 248.1% above the Medical Distribution median (#27 of 115)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
85GF Score
Get the complete analysis for ISX:SOHO
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
